| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/03/2014 | WO2014004572A2 Modulation of ube3a-ats expression |
| 01/03/2014 | WO2014003830A1 Particle-nucleic acid conjugates and therapeutic uses related thereto |
| 01/03/2014 | WO2014003821A1 Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples |
| 01/03/2014 | WO2014003744A1 Anti-cxcl9, anti-cxcl 10, anti-cxcl 11, anti-cxcl 13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder |
| 01/03/2014 | WO2014003742A1 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation |
| 01/03/2014 | WO2014002108A1 A core-shell nanostructure on the basis of proteins with corresponding therapeutic agents |
| 01/03/2014 | WO2014001988A2 USE OF CTBP1 siRNA FOR THE TREATMENT OF GASTRIC CANCER |
| 01/03/2014 | WO2014000026A1 Recombinant viral vectors and uses therefor |
| 01/03/2014 | CA2876165A1 Particle-nucleic acid conjugates and therapeutic uses related thereto |
| 01/02/2014 | US20140005257 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 01/02/2014 | US20140005250 Compositions and Methods for Increasing Drug Efficacy in Cancer |
| 01/02/2014 | US20140004196 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 01/02/2014 | US20140004143 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004089 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/02/2014 | US20140004072 Polyethyleneimine And Beta2-Adrenergic Receptor Based Gene Therapy For Acute Lung Injury |
| 01/01/2014 | EP2679598A1 T cell receptors and related materials and methods of use |
| 01/01/2014 | EP2679246A2 Novel therapeutical tools and methods for treating blindness |
| 01/01/2014 | EP2679237A1 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 01/01/2014 | EP2678354A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| 01/01/2014 | EP2678043A2 Recombinant mumps virus vaccine |
| 01/01/2014 | EP2678034A2 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin |
| 01/01/2014 | EP2678019A2 Method and cells for identifying rig-i pathway regulators |
| 01/01/2014 | EP2678007A2 Protein nanocarriers for topical delivery |
| 01/01/2014 | EP2677863A1 Modified pig islets for diabetes treatment |
| 01/01/2014 | EP1682573B1 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 01/01/2014 | CN103491982A In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
| 01/01/2014 | CN103491977A Combination therapy for cancer |
| 01/01/2014 | CN103491965A Method and cells for identifying rig-i pathway regulators |
| 01/01/2014 | CN103484463A shRNA for silencing human c2orf68 gene, and medical use thereof |
| 01/01/2014 | CN103484462A Construction of recombinant adenovirus vector for regulating and controlling cytosine deaminase (CD) gene by Survivin promoter and application thereof |
| 01/01/2014 | CN103484460A Oligonucleotide and its derivatives, and applications thereof |
| 01/01/2014 | CN103483453A Chimeric antigen receptor combining EGFR (epidermal growth factor receptor) family proteins and composition and uses thereof |
| 01/01/2014 | CN103483452A Dual-signal independent chimeric antigen receptors (dsCAR) and uses thereof |
| 01/01/2014 | CN103483441A Rhesus monkey NY-ESO-1 protein, coding gene, and applications thereof |
| 01/01/2014 | CN103483431A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 01/01/2014 | CN103483421A Polypeptide used for treating HBV infection and related diseases, and antibodies thereof |
| 01/01/2014 | CN103480004A Application of Hsa-miR-503 in preparation of drug for treating glioma |
| 01/01/2014 | CN103480003A Novel HIV vaccine for triggering efficient CD4+T lymphocyte immune response |
| 01/01/2014 | CN103480002A Administering antisense oligonucleotides complementary to human apolipoprotein b |
| 01/01/2014 | CN102512661B Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same |
| 01/01/2014 | CN102512660B Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same |
| 01/01/2014 | CN101760474B EMX2 adenovirus vector and application thereof |
| 01/01/2014 | CN101001646B Stabilized synthetic immunogen delivery system |
| 12/31/2013 | US8618277 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/31/2013 | US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 12/31/2013 | US8618071 Oligonucleotides for suppressing cancer cell invasion and migration |
| 12/31/2013 | US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist |
| 12/31/2013 | US8617810 Screening method for compounds that promote differentiation of inner ear progenitor cells |
| 12/31/2013 | US8617565 Surface exposed Haemophilus influenzae protein (protein E; pE) |
| 12/31/2013 | US8617535 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 12/31/2013 | US8617534 Compositions and method for manipulating PIM-1 activity in circulatory system cells |
| 12/31/2013 | US8617533 Multi-antigenic alphavirus replicon particles and methods |
| 12/31/2013 | CA2543257C Methods and compositions for delivering polynucleotides |
| 12/31/2013 | CA2478371C Compositions and methods for generating an immune response |
| 12/31/2013 | CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages |
| 12/31/2013 | CA2421584C Gene therapy for cardiac arrythmias |
| 12/27/2013 | WO2013192486A1 Inhibitors of the mir-15 family of micro-rnas |
| 12/27/2013 | WO2013192364A1 Treatments of oxidative stress conditions |
| 12/27/2013 | WO2013192317A2 Compositions and methods for treating diabetes |
| 12/27/2013 | WO2013191445A1 Pharmaceutical composition for colon cancer treatment or metastasis suppression, comprising cadherin-11 protein expression or action suppressing agent |
| 12/27/2013 | WO2013191242A1 Test method and treatment means for small cell lung cancer having poor prognosis |
| 12/27/2013 | WO2013190059A1 Widespread gene delivery of gene therapy vectors |
| 12/27/2013 | WO2013189309A1 Microparticle comprising functional microrna/sirna and application thereof |
| 12/27/2013 | WO2013189004A1 Peptide nucleic acid of porcine reproductive and respiratory syndrome virus and uses thereof |
| 12/27/2013 | WO2013189003A1 Peptide nucleic acid of subgroup j avian leukosis virus and uses thereof |
| 12/27/2013 | CA2877428A1 Widespread gene delivery of gene therapy vectors |
| 12/27/2013 | CA2876180A1 Oligonucleotide-based inhibitors comprising locked nucleic acid motif |
| 12/27/2013 | CA2876105A1 Inhibitors of the mir-15 family of micro-rnas |
| 12/27/2013 | CA2875523A1 Compositions and methods for treating diseases |
| 12/26/2013 | US20130345409 Growth factor |
| 12/26/2013 | US20130345294 Light-Switchable Gene Expression System |
| 12/26/2013 | US20130345291 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/26/2013 | US20130344117 Pegylated polyplexes for polynucleotide delivery |
| 12/26/2013 | US20130344040 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| 12/25/2013 | EP2675902A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
| 12/25/2013 | EP2675484A2 Improved aav8 vector with enhanced functional activity and methods of use thereof |
| 12/25/2013 | EP2675483A2 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications |
| 12/25/2013 | EP2675474A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
| 12/25/2013 | EP2397487B1 Short-chain cationic polyamino acid and use thereof |
| 12/25/2013 | CN103477228A Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
| 12/25/2013 | CN103476947A Enhanced biodistribution of oligomers |
| 12/25/2013 | CN103468786A Uses and relevant drugs of human CDKL3 (cyclin-dependent kinase-like 3) gene |
| 12/25/2013 | CN103468785A Uses and relevant drugs of human SEMA4C (semaphorin 4C) gene |
| 12/25/2013 | CN103468725A Construction and application of PTEN gene overexpression recombinant adenoviral vectors |
| 12/25/2013 | CN103468681A siRNA (small interfering ribonucleic acid) inhibiting expression of versican 1 and application of siRNA |
| 12/25/2013 | CN103468680A Novel antidiabetic medicine |
| 12/25/2013 | CN103467583A Variants of group 1 allergens of poaceae with reduced allergenicity and a maintained t-cell reactivity |
| 12/25/2013 | CN103467570A Transmembrane polypeptide with analgesic effect |
| 12/25/2013 | CN103467569A Short peptide for bacterium resisting, itching relieving, inflammation diminishing, swelling eliminating and scar removing, and its application |
| 12/25/2013 | CN103463646A Application of E2F1 protein in preparation of medicine for diagnosing and treating osteosarcoma |
| 12/25/2013 | CN103463645A Fish Vibrio. alginolyticus anti-idiotype antibody genetic engineering vaccine and preparation method thereof |
| 12/25/2013 | CN102220357B Multivalent vaccines comprising recombinant viral vectors |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/24/2013 | US8614305 Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (VIPER) |
| 12/24/2013 | US8614300 Nucleic acids encoding a mut-T domain-containing polypeptide |
| 12/24/2013 | US8614198 Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use |
| 12/24/2013 | US8614177 Peptides |
| 12/24/2013 | US8613915 Attenuated strain of myxoma virus for use as an oncolytic drug |
| 12/24/2013 | CA2682108C Methods for generating high titer helper-free preparations of recombinant aav vectors |